Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate to severe plaque psoriasis by Paolo Dapavo, Matteo Megna, Marina Talamonti

Connect to this object online.

Successful long‐term guselkumab treatment of severe plaque psoriasis in patients with class III obesity: A case series by Marco Galluzzo, Lorenzo Marcelli, Angela Fico, Luca Bianchi, Marina Talamonti

Connect to this object online.

Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases by Rosita Saraceno, Marina Talamonti, Marco Galluzzo, Andrea Chiricozzi, Antonio Costanzo, Sergio Chimenti

Connect to this object online.

Letter in response to the case report: "Recalcitrant generalized granuloma annulare treated successfully with dupilumab" by Claudia Paganini, MD, Marina Talamonti, MD, Elena Campione, MD, Luca Bianchi, MD, Marco Galluzzo, MD

Connect to this object online.

Eczematous liraglutide eruption managed by dupilumab: A case report by Claudia Paganini, MD, Alfredo Belcastro, MD, Angela Fico, MD, Marina Talamonti, MD, Luca Bianchi, MD, Marco Galluzzo, MD

Connect to this object online.

Dupilumab‐associated ocular surface disease or atopic keratoconjunctivitis not improved by dupilumab? Upadacitinib may clarify the dilemma: A case report by Marco Galluzzo, Lorenzo Tofani, Sara Spelta, Marina Talamonti, Alessandra Micera, Luca Bianchi, Marco Coassin, Stefano Bonini, Antonio Di Zazzo

Connect to this object online.

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study by Marina Talamonti, Giovanna Malara, Ylenia Natalini, Federico Bardazzi, Andrea Conti, Andrea Chiricozzi, Cristina Mugheddu, Paolo Gisondi, Stefano Piaserico, Gianluca Pagnanelli, Paolo Amerio, Concetta Potenza, Franca Cantoresi, Maria Concetta Fargnoli, Anna Balato, Francesco Loconsole, Annamaria Offidani, Claudio Bonifati, Francesca Prignano, Marta Bartezaghi, Alice Rausa, Elisabetta Aloisi, Roberto Orsenigo, Antonio Costanzo

Connect to this object online.

A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study by Emanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Marina Talamonti, Matteo Megna, Massimo Raspanti, Matteo Paolinelli, Katharina Hansel, Alessandra Narcisi, Andrea Conti, Clara De Simone, Marco Adriano Chessa, Alina De Rosa, Eugenio Provenzano, Michela Ortoncelli, Chiara Moltrasio, Rosaria Fidanza, Martina Burlando, Annalisa Tonini, Francesca Maria Gaiani, Lucia Simoni, Alessandro Zullo, Martina Fiocchi, Delia Colombo

Connect to this object online.